title: Infusion of ovine C5a into sheep mimics the inflammatory response of hemodialysis.
abstract: Previous studies in our group have explored the inflammatory response in sheep to dialysis with a variety of different hemodialysis membranes. In the present study we investigated the potential role of C5a in mediating inflammatory responses that have been attributed to complement activation in the extracorporeal setting. Sheep C5a was infused into sheep in a manner that simulated exposure to this anaphylatoxin during dialysis. C5a infusion into sheep was shown to produce a dose-dependent neutropenia that was quantitatively and temporally identical to the response of sheep undergoing dialysis with complement-activating membranes. The two lowest doses used (0.25 and 0.50 micrograms/kg), which resulted in concentrations below the detectable limits of current assays (10 ng/ml), produced significant neutropenia (21.8% and 78.1%, respectively). The ability of the neutrophils (PMNs) to bind fluorescein isothiocyanate-C5a or initiate a respiratory burst in response to phorbol myristate acetate were also affected in a dose-dependent manner. In contrast, C5a alone was not able to produce significant release of lactoferrin, a specific granule constituent, suggesting that degranulation of PMN-specific and primary granules requires secondary stimuli. The production of thromboxane A2 and thromboxane's consequent cardiopulmonary effect of increasing mean pulmonary artery pressure were both observed in a dose-dependent fashion. However, larger amounts of C5a were required to elicit these latter responses as compared with the PMN activities. These results suggest that C5a may be a primary mediator of complement-dependent events that occur during extracorporeal therapies such as hemodialysis, and they also suggest that very little complement activation is necessary to activate leukocytes, whereas higher thresholds are required to produce cardiopulmonary responses.
authors.affiliation: Baxter Healthcare Corporation, Round Lake, IL USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Johnson
authors.forename: K E
authors.initials: KE
authors.lastname: Burhop
authors.forename: D E
authors.initials: DE
authors.lastname: Van Epps
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001794:Blood Pressure; D015936:Complement C5a / Q000008:administration & dosage* / Q000378:metabolism; D004195:Disease Models, Animal; D016650:Fluorescein-5-isothiocyanate; D005456:Fluorescent Dyes; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D007700:Kinetics; D007958:Leukocyte Count; D008969:Molecular Sequence Data; D009503:Neutropenia / Q000139:chemically induced; D009504:Neutrophils / Q000502:physiology; D006435:Renal Dialysis; D016897:Respiratory Burst; D017385:Sequence Homology; D012756:Sheep; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
chemical_list: D005456:Fluorescent Dyes; D015936:Complement C5a; D016650:Fluorescein-5-isothiocyanate; D013755:Tetradecanoylphorbol Acetate